ArticleBlood2013

Neurokinin-1 receptor agonists bias therapeutic dendritic cells to induce type 1 immunity by licensing host dendritic cells to produce IL-12.

Brian M Janelsins et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.